notype is not the null white or the saturated brick red of wild type. Therefore, modulations of the dosage of this allele are reflected in the phenotype. Muller produced a heterozygous deficiency for the white locus and whiteapricot and observed that the color was lighter than in a female with 2 copies of the allele and interestingly also compared to a male that had only 1 copy that exhibits a similar level of pigment as the females ( fig. 2 ). Muller further constructed flies with extra copies of white-apricot and found an increased amount of pigment beyond the normal female and an even further increase when the extra copy was present in a male. In other words, a dosage series of white-apricot in females gave a proportional amount of pigment in the eyes, but each copy in the male was expressed by about 2-fold greater while still showing a dosage effect.
Richard Goldschmidt questioned whether the X chromosome exhibited any special mechanism with regard to upregulation because, as he pointed out, many autosomal leaky mutations are also more like wild type in males than in females [Goldschmidt, 1954] . This is indeed the case [Smith and Lucchesi, 1969; Birchler, 1984] , but the magnitude of the increase and fraction of genes on the autosomes exhibiting this effect is much less than the fraction of the X-linked genes that exhibit compensation. The commonly used mini-white transformation phenotypic marker shows this effect when inserted autosomally [e.g. Birchler, 1992; Bhadra et al., 1999] ( fig. 3 ) .
Triple X females, or metafemales as they are called, seldom survive to the adult stage but are represented in larval stages to some degree. Muller [1950] rationalized this lethality by suggesting that the total gene expression from the 3 X chromosomes was decreased below the normal female level in the progression from 1 X in males to 2 X in normal females to 3 in metafemales. However, Curt Stern [1960] found that metafemales homozygous for white-apricot showed the same amount of pigment as the normal females. In retrospect, previous description of the behavior of the Bar eye shape mutation in metafemales is consistent with the same level of dosage compensation [Margolis, 1934] . Below, a further discussion of the situation in metafemales will be detailed.
Triploid Dosage Compensation
Dosage compensation has also been documented in triploid flies that have 3 copies of the genome. A fly with 3 sets of all chromosomes is a triploid female. When gene expression is sampled in triploid and diploid flies, there The white eye color gene in Drosophila . The white eye color gene has played a prominent role in understanding dosage compensation of the X chromosome in Drosophila . The normal brick red eye color is at the lower left. The null mutant white color is at the lower right. The leaky or hypomorphic white-apricot allele for which dosage modulations can be observed is at the top. Photo by James A. Birchler. 
-copy female w[a]/w[a] (lower right). When w[a]
is heterozygous for a deficiency of white, Df(1)w (top), the eyes of this fly with 1 copy of apricot are lighter in color than in the normal male and female. When the whole chromosome is in 1 copy, there is a 2-fold upregulation that does not occur when only the apricot allele is varied -the phenomenon of dosage compensation. Photo by Weiwu Xie. is basically a directly proportional amount of gene product in relation to the number of genomes present [Lucchesi and Rawls, 1973a; Rabinow et al., 1991] . When the X chromosome is reduced to 2 copies in an otherwise triploid fly, it develops as a mixture of male and female tissues, but the amount of gene expression from the 2 X chromosomes is about equal to that of the triploid females [Lucchesi and Rawls, 1973b; Maroni and Plaut, 1973] . If the dosage of the X chromosome is reduced even further to 1 dose, these flies are referred to as metamales. They usually do not survive to the adult stage, but assays of gene expression in larvae show that the single X chromosome is upregulated to near the triploid female level [Lucchesi et al., 1977] . These results indicate that the magnitude of change for dosage compensation is a 3/2× increase for triploid intersexes and a 3× increase for metamales. When considering all genotypes, diploid and triploid females have a similar level of gene expression per gene; normal males have an approximately 2-fold upregulation per gene; metafemales have an approximately 2/3 downregulation per gene; triploid intersexes have a 3/2 upregulation and triploid metamales have a 3-fold increase per gene. Thus, there are 5 levels of gene expression that need to be explained for a valid model of dosage compensation [Birchler, 1996] ( fig. 4 ).
The white Locus and What It Tells Us about Dosage Compensation
The first cases of dosage compensation were defined using the white-apricot allele of the white eye color gene. The beauty of this system is that it is easy to score and the measure of gene expression can be determined visually as a pigment 'per cell' measure. The full wild-type alleles are saturated for pigment, but those that are partial loss-of-function alleles permit a straightforward determination. Most such leaky alleles show similar expression between males and females indicating dosage compensation. The mini-white transgene that is used routinely as a transformation marker has reduced function because part of its regulatory sequences has been deleted. Further deletion to the bare minimum 5 ′ sites did not reveal a sequence required for dosage compensation -all show it [Hazelrigg et al., 1984; Levis et al., 1985] . Some other alleles are instructive: eosin , apricotlike and ivory all fail to show equal expression between males and females [Karess and Rubin, 1982; Zachar and Bingham, 1982; Rabinow et al., 1991; Birchler, 1992] . They are all lesions in the 5 ′ regulatory sequence, in the first 2 cases being transposable element insertions that likely provide a different promoter for the white structural gene. Another set of alleles are the spotted series. In this case, the eye enhancer is deleted [Zachar and Bingham, 1982] . These alleles exhibit a variable level of Fig. 3 . Male-biased sexual dimorphism of the autosomal miniwhite transgene. The mini-white transgene marker is used extensively for transformation in Drosophila . When transgenes are inserted in an autosomal location, the most common effect is that the male (right) shows greater pigment amounts than the female (left) illustrating a male-biased sexual dimorphism in autosomal expression. Photo by Lin Sun. Fig. 4 . Dosage compensation in diploid and triploid flies. Dosage compensation not only occurs in normal diploid males and females but also in triple X metafemales (m ♀ ). In triploid flies, 3 copies of all chromosomes is a triploid female, which has a similar 'per gene' expression as a diploid female, but there are 3 copies present resulting in a 1.5× total expression per cell compared to diploids. Triploid flies with only 2 X chromosomes are triploid intersexes, which exhibit dosage compensation. The single X condition in triploids is a metamale (m ♂ ), which also shows compensation. Purple bars represent X chromosome number (X) and white bars represent the collective autosome copy number (A). For these 6 genotypes, there are 5 levels of 'per gene' expression that in the respective cases are the inverse of the chromosomal imbalance.
expression, but there is a greater amount of pigment in males than in females. Collectively, the white alleles provide a natural deletion series and promoter substitution analysis that suggest that dosage compensation is a transcriptional initiation phenomenon or, at the very least, initiation is a critical step.
Another contribution that studies of the white locus have made to the field of dosage compensation involves a comparison of the reaction of these various alleles to dosage compensation in triple X metafemales [Birchler, 1992] . When eosin and ivory were incorporated into an attached X and then used to generate triple X females, both showed increased expression in metafemales in contrast to the male/female compensating alleles, apricot and blood , which were both equal in expression between meta-and normal females. With 2 white-spotted alleles, the amount of pigment in metafemales was decreased. Thus, noncompensation, compensation and overcompensation, respectively, in males versus females were also found in metafemales. In other words, alleles expressed less in males than in females are expressed even more in metafemales, and alleles with similar expression between males and females extend this relationship to metafemales. Alleles with more expression in males than females have even less in metafemales. Collectively, these results indicate that dosage compensation in males and metafemales has a related mechanism.
Autosomal Sexual Dimorphism in Males
As noted above, Richard Goldschmidt [1954] had pointed out that many hypomorphic mutations of autosomal genes exhibit a more wild-type expression in males than in females. This is obviously the case by observation of mutations in such eye color genes as purple , pink [peach] , light , and glass, as examples (FlyBase, flybase.org) [see also Birchler et al., 1989] . All Drosophilists recognize autosomal insertions of mini-white as routinely darker in males than in females ( fig. 3 ). Another transgene that can be observed in the eye is the Alcohol dehydrogenase promoter-white structural gene fusion. Autosomal insertions also have higher expression in males [Birchler et al., 1990; Pal Bhadra et al., 1999] . The molecular nature of these genes is known in some cases (flybase.org) and is quite diverse indicating that this malebiased sexual dimorphism is not specific to a certain class of gene.
Male-Specific Lethal Mutations and Their Hypothesized Role in Dosage Compensation
A popular model invoked to explain dosage compensation in Drosophila involves the products of the malespecific lethal (MSL) loci [Belote and Lucchesi, 1980; Lucchesi et al., 2005; Lucchesi and Kuroda, 2015] . These mutations are lethal as homozygotes in males but not in females. The lethality is usually manifested at the transition from the larval to the pupal stage. These mutations include maleless (mle) [Belote and Lucchesi, 1980] and the male-specific lethal 1, 2 and 3 (msl1, msl2, msl3) loci as well as the males absent on the first (mof) [Hilfiker et al., 1997] . Some decades ago, the maleless mutation was examined for its effect on transcription by studying the incorporation of tritiated uridine into nascent RNA on the X chromosome versus a portion of the autosomes [Belote and Lucchesi, 1980] . The ratio of incorporation on the X chromosome relative to the autosomal values was reduced. This result was interpreted such that the products of the male-specific lethal genes were responsible for X chromosomal dosage compensation.
When the product of the mle gene was identified and localized in the nucleus, it was present on the X chromosome of males [Kuroda et al., 1991] . As the other protein components were identified, they followed the same pattern. One of the later identified protein products, MOF, encodes a histone acetyl transferase that is responsible for acetylation of lysine 16 on histone H4 (H4K16Ac) [Hilfiker et al., 1997] . Accordingly, this histone modification is enriched on the male X chromosome [Turner et al., 1992; Bone et al., 1994] . These findings led to the hypothesis that a complex composed of the MSL proteins brought the histone modifier MOF to the X chromosome in males to cause the upregulation of the single X chromosome. There are also 2 loci (roX1 , roX2) that encode RNAs without proteincoding capacity of which at least one must be present for the integrity of the complex [Meller et al., 1997; Meller and Rattner, 2002] . The JIL1 histone kinase, which phosphorylates H3Ser10, is also enriched on the male X chromosome, although mutations in this gene are not specifically male lethal [Jin et al., 1999 [Jin et al., , 2000 Wang et al., 2001] . There is an extensive literature on the composition of the MSL complex and its X chromosome targeting that is integral to both models discussed here [see Lucchesi and Kuroda, 2015] .
The sex specificity of MSL association with the male X chromosome is determined by the expression of the Sexlethal gene [Kelley et al., 1995 [Kelley et al., , 1997 . This gene is a splicing factor that initiates its own splicing in females, but in males a disruptive exon remains throughout development because the protein is never expressed sufficiently highly to remove it [Cline and Meyer, 1996] . In females, SXL splices itself to allow continued expression and a cascade of splicing occurs to determine sexual differentiation. The SXL protein binds to the mRNA of the MSL2 protein and blocks its expression in females. The absence of the SXL protein in males allows the expression of MSL2. MSL2 is the critical component of the MSL complex that draws the complex to the X chromosome [Kelley et al., 1995] .
This body of work provides an apparently satisfying explanation for dosage compensation of the single male X chromosome. The MSL complex is localized to the male X chromosome. This concentration brings to the chromosome a histone modifier (MOF) that is otherwise known to be involved with increased gene expression. Mutation in one of the components (mle) that dissociates the complex from the X chromosome produces a relative change of X and autosomal gene expression. Collectively, these facts seem to provide a simple explanation for the mechanism of dosage compensation.
One line of argument that the MSL complex causes dosage compensation involved the observations that autosomal insertions of the roX RNA transgenes will attract the complex, which can spread out from the site of insertion [Park et al., 2002; Kelley and Kuroda, 2003] . One such transgene with mini-white being present as the transformation marker shows white expression only in the dorsal portion of the eye. However, in males in which the spreading was most extensive, the silenced ventral portion of the eye was derepressed to almost wild type in males. Subsequently, a second site mutation, called over compensating male (ocm) [Lim and Kelley, 2013] was recovered that caused strong derepression of this phenotype. These results were interpreted such that this MSL complex association with the mini-white reporter caused the acquisition of dosage compensation. However, dosage compensation is a 2-fold modulation rather than a depression of a null state. Another potential explanation of these results is that the MSL complex overrides this type of silencing. In this context, it is interesting to note that the MSL complex appears to override the impact of gene-activating chromatin marks [Sun et al., 2013a ], which will be described in more detail below.
Evidence for Genomic Balance and the Inverse Effect
Before delving further into the specifics of dosage compensation models, we review the evidence for genomic balance in general, which is a critical factor for understanding the driving force for dosage compensation and sex chromosome evolution. The idea of genomic balance, namely that varying copies of individual chromosomes has more detrimental effects on the phenotype than does varying the complete set, has a long history of investigation on the phenotypic level [Blakeslee et al., 1920; Bridge, 1925; Blakeslee, 1934] . More recently, parallels have emerged from studies of gene expression and genome evolution enabling the formulation of a broader synthesis that attempts to address the molecular basis of this phenomenon. This synthesis has been referred to as the gene balance hypothesis (GBH) Birchler and Veitia, 2012] . The GBH posits that altering the stoichiometry of members of oligomeric complexes will affect the function of the whole as a result of the kinetics and mode of assembly Birchler and Veitia, 2012] . While the GBH applies to any multisubunited complex or interaction hierarchy of genes, we will focus on how regulatory gene balance operates.
Evidence from gene expression studies in both plants and animals suggests there is a widespread importance for maintaining genomic balance. Aneuploid samples of maize or Drosophila exhibit more modulations of gene expression than do balanced changes in ploidy [Birchler et al., 2001] . The modulations of enzyme activities, protein and RNA levels that change in aneuploids usually fall within the range of either direct or inverse correlations with the dosage of the varied chromosome [Birchler, 1979; Birchler and Newton, 1981; Devlin et al., 1988; Sabl and Birchler 1993; Guo and Birchler, 1994; Sun et al., 2013b, c] . Trans -acting direct effects show reductions to 50% in monosomics compared to a diploid and increase to 150% of the diploid in trisomics. The more common trans -acting inverse effects show increases to 200% in monosomics and reductions to 67% in trisomics. Multiple segments of the genome can modulate any one gene product [Birchler and Newton, 1981; Guo and Birchler, 1994] . Any one chromosome arm can modulate differing numbers of the total detectable proteins [Birchler and Newton, 1981] . Evidence for the inverse effect in several organisms is present in segmental trisomy data [see Birchler, 2010; Nawata et al., 2011; Sun et al., 2013b, c] . Such molecular variations are less often observed for balanced changes in ploidy [Lucchesi and Rawls, 1973a; Guo et al., 1996] . This comparison led to the postulation that altering the stoichiometry of regulatory genes might be responsible for these effects [Birchler and Newton, 1981] .
Whenever a regulatory gene producing an inverse dosage effect and a subset of its target loci are varied on the same chromosomal segment, dosage compensation is ob-served [Birchler, 1979 [Birchler, , 1981 Birchler et al., 1990] . In other words, increasing the dosage of an inverse regulator at the same time as a target gene, which otherwise would show a dosage effect, would restore the original diploid expression level [Birchler, 1979 [Birchler, , 1981 Devlin et al., 1982; Birchler et al., 1990; Sun et al., 2013a, b] because the 2 opposing effects cancel each other. The first described example involved the alcohol dehydrogenase (adh1) gene on the long arm of chromosome 1 (1L) in maize [Birchler, 1979 [Birchler, , 1981 . Compensation also operates on the RNA level [Guo and Birchler, 1994] . Similar examples were demonstrated in Drosophila [Devlin et al., 1982; Birchler et al., 1990; Sun et al., 2013a, b] .
Global studies of gene expression in Drosophila using RNA-Seq of trisomy of the X chromosome [Sun et al., 2013b] or of the left arm of chromosome 2 [Sun et al., 2013c] illustrate the ubiquitous nature of the inverse effect. The plurality of all isoforms detected in both trisomy of the X and 2L is inversely affected by the extra chromosome. In parallel, most of the genes on the varied chromosomes are dosage compensated, although some fraction in each case exhibits a dosage effect. Furthermore, there is a sexual dimorphism for the type of effects with one potential explanation being that the reduced dosage of the X chromosome in males intensifies the inverse effect of 2L [Sun et al., 2013c] . Also, the X chromosome responds differently to trisomy of 2L, which was suggested as a reflection of the X evolving to maximize using the inverse dosage effect to bring about dosage compensation of the X [Sun et al., 2013c] . Indeed, genes with sex-biased expression are strongly skewed in their response to trisomy 2L implicating the inverse effect in mediating such sex differential expression.
The inverse and direct effects on gene expression observed in aneuploids could be mimicked at the level of single genes by recovering modifier mutations that, in the heterozygous condition, doubled or reduced by half the expression of a leaky allele of the white eye color reporter gene in Drosophila [e.g. Rabinow et al., 1991] . The first and most thoroughly studied, Inverse regulator-a , produces a near perfect inverse effect on the phenotype of the white eye color gene in both diploid and triploid flies [Rabinow et al., 1991] . This gene is synonymous with the Pcf11 gene, which is involved with transcriptional initiation, elongation and termination reactions [Xie and Birchler, 2012] . A collection of 47 such dosage-dependent modifiers of white eye color gene expression was recovered over 2 decades of screening [Birchler et al., 2001] with the majority showing an increased effect on white, when the modifier was heterozygous, while others reduced the expression. It is an interesting question of how there can be such a large number of modifiers of a single reporter gene. The answer likely resides in the fact that gene regulatory systems operate in a hierarchy with one regulator controlling downstream effectors, which, in turn, control other regulators ultimately reaching the phenotype [Birchler et al., 2001] . Moreover, regulatory processes are often performed by oligomeric complexes such that modulating different subunits affects the action of the whole. Modeling the kinetics of ordered assembly of multi-subunit complexes predicts such effects [Bray and Lay, 1997] . Other chromatin modifiers are also dosage dependent [Henikoff, 1996] .
The molecular nature of many dosage modifiers has been elucidated, which were found to encode transcription factors, chromatin proteins or members of signal transduction cascades [Birchler et al., 2001] . Collectively, this result parallels the realization that most haploinsufficient clinical conditions in human are lesions in transcription factors or other proteins involved with oligomeric complexes [Seidman and Seidman, 2002; Veitia, 2002; Kondrashov and Koonin, 2004] . Gene dosage has an effect on murine phenotypes when mutations in developmental transcriptional regulators are present in a heterozygous state [Boell et al., 2013] .
Modeling of haploinsufficiencies has led to the idea that the stoichiometry of interacting subunits would generate a semi-dominant effect on the phenotype based on the action on the target loci [Veitia, 2002] . An experimental demonstration of this principle was provided by evidence from diploid yeast in which the heterozygote fitness was measured for null mutations in essential genes. As the genes were grouped into bins of different heterozygous fitness, a greater proportion were involved in protein complexes as the fitness declined [Papp et al., 2003 ]. Furthermore, overexpression of genes involved in complexes is also detrimental, which can be corrected by coupregulation of interactors. These results mirror aneuploid effects but on the single gene level.
Gene balance is relevant to how genomes evolve through chromosome doubling and subsequent gene loss. For example, it has been realized that polyploidization events have been quite common in the evolution of eukaryotes [Wolfe and Shields, 1997; Simillion et al., 2002; Bowers et al., 2003; Maere et al., 2005; Aury et al., 2006; Blomme et al., 2006; Makino and McLysaght, 2010; Conant et al., 2014] . In fact, almost all eukaryotes have a history of ancient polyploidization events followed by fractionation to a near diploid state and then repeated polyploidizations and fractionations. In the plant Arabi-dopsis , analysis of gene duplicates provided evidence of at least 3 whole-genome duplications stretching back a quarter of a billion years [for review, see Freeling, 2009] . In Paramecium tetraurelia , there are 3 tetraploidization events that can be documented from the analysis of the sequenced genome, each followed by a reduction in gene number [Aury et al., 2006] , illustrating the generality across phylogenetic kingdoms.
Interestingly, as chromosomal segments are lost following polyploidization events, the spectrum of retained genes is not random. Indeed, in the independent fractionations in yeast, Arabidopsis , rice, Paramecium and vertebrates, the classes of genes retained are preferentially represented by those that are members of oligomeric complexes [Blanc and Wolfe, 2004; Aury et al., 2006; Freeling and Thomas, 2006; Hakes et al., 2007; Edger and Pires, 2009; Makino and McLysaght, 2010] . For example, duplicates of transcription factors and members of signal transduction pathways are typically maintained -both categories of gene products are involved with complexes and interacting hierarchies. Thus, the same classes of genes are held in duplicate as those that show dosage effects as regulatory modifiers and quantitative trait determinants. It seems likely that there is selection to retain a stoichiometry of these gene products and that deletion of one member of a duplicate pair might act like an aneuploid effect that is selected against due to reduced fitness. This supports the idea that genes with major regulatory roles are retained to maintain balance in the genome over evolutionary time. These considerations would apply to sex chromosome degeneration as well but have not been examined in detail with some exceptions [Makino and McLysaght, 2010; Pessia et al., 2012; Bellott et al., 2014] .
That duplicate pairs are retained in such a manner implies that dosage is important. This fact also illustrates that only a restricted range of perturbation appears to be tolerated. For instance, following a whole-genome duplication involving diploid contributors, there would be 4 copies of a particular transcription factor gene instead of the two present in the original diploid species. The fact that duplicates are retained suggests that a mere reduction to only 3 functional copies causes reduced relative fitness in the population. Furthermore, isolated duplication of genes encoding subunits of complexes are usually selected against due to unbalanced, and therefore detrimental, dosage. Accordingly, these gene classes are underrepresented in genomic analyses of copy number variants in several organisms [Yang et al., 2003; Maere et al., 2005; Freeling and Thomas, 2006; Freeling et al., 2008; Makino and McLysaght, 2010; Schuster-Böckler et al., 2010] . Thus, there is a generalized complementary pattern of gene ontologies present in segmental duplications compared to those that are retained for longer time periods following polyploidization events. These evolutionary trajectories are consistent with the laboratory results that aneuploidy is typically of more detrimental consequence to an organism compared to whole-genome ploidy effects. Understanding how sex chromosome evolution has accommodated these issues is worthy of investigation.
A Critique of the MSL Hypothesis
Despite the simplicity of the MSL hypothesis, there are many biological facts that it does not explain with regard to dosage compensation. First of all, female flies that possess 3 copies of the X chromosome, a genotype referred to as metafemales [Margolis, 1934; Stern, 1960; Lucchesi et al., 1974; Birchler et al., 1989; Birchler, 1992; Sun and Birchler, 2009; Sun et al., 2013b] exhibit dosage compensation. In this case there must be a downregulation of the X chromosomes for dosage compensation to occur. Each gene must be expressed at approximately two-thirds of the level in a normal female. And because there is no MSL complex in females, including metafemales [Sun and Birchler, 2009] , this compensation cannot be mediated by the MSL complex. A sampling of endogenous autosomal genes had revealed that many of them are reduced in expression in metafemales relative to the normal female levels [Birchler et al., 1989; Sun and Birchler, 2009] . One can visualize this effect on the phenotypic level using partial loss-of-function alleles whose modulation could be assayed in the fly [Birchler et al., 1989] . These autosomal sexually dimorphic eye color mutations that typically are darker in males than in females show an even greater reduction in metafemales illustrating the continued trend with the dosage series of the X chromosome in males, females and metafemales [Birchler et al., 1989] . Specific endogenous RNA levels were also examined in adults [Birchler et al., 1989] and larvae [Sun and Birchler, 2009] with standardization to ribosomal RNA and in turn to DNA. There was compensation of the X-linked genes and reductions for the autosomal loci. Thus, the gene copies on the 3 X's produce about the same amount as a normal female with 2 X's, and the diploid autosomes in metafemales produce less than they do in normal females.
On the global transcriptome level, an RNA-Seq experiment on larvae compared metafemales to females (and males). When the data are expressed as a ratio distribution, the majority of genes on the X chromosome were in fact dosage compensated with a small peak that exhibited an expression ratio of 1.5 (a dosage effect) [Sun et al., 2013b] . For autosomal genes, the plurality was reduced to near 67% (the inverse of the 3/2 X dosage) in metafemales compared to normal females with a peak shoulder being unaffected with an expression ratio of 1.0. These data illustrate the pervasiveness of the inverse dosage effect and the generalized X chromosome compensation in metafemales. They also provide a potential explanation of the reduced viability of metafemales. As noted above, Muller suggested that this was due to a multiplicatively reduced X expression, but there are in fact comparable levels of expression for this chromosome in normal and metafemales. The autosomal reductions could potentially provide an explanation for the inviability effects.
Another consideration is that when endogenous genes were sampled for their absolute rather than relative level of expression in the mle mutation, most of the genes on the X chromosome in the mutant males did not lose dosage compensation, while many of the autosomal genes were actually increased in expression [Hiebert and Birchler, 1994] . In further studies using transgenes for the white eye color and the yellow body genes on the X and the autosomes, it was found that disruption of the MSL complex with the mle mutation did not cause a loss of dosage compensation of either transgene, but the autosomal copies in each case were increased in expression within an about 2-fold range . As these studies were conducted in larvae, one concern about the results is that they were assayed near the developmental stage at which they normally die. Thus, an RNA-FISH assay was developed for embryos and selected X and autosomal genes were examined for their levels of expression [Pal Bhadra et al., 2005] . As was the case in larvae, the Xlinked genes did not show a loss of dosage compensation and expression of the autosomal genes studied was increased. The consistency of these results across the different developmental stages indicates that the concerns about the larval data were unfounded.
The genomic distribution of MOF relates to the gene expression results. In normal females, there is a low level of association with all chromosomes but it becomes highly concentrated on the male X ; see also Kind et al., 2008] . In the mle mutant males, when compared in a mixed slide preparation with normal males, there is a redistribution of MOF to being uniform across the genome. This result is accompanied by a genomewide uniform acetylation of H4 . Considering that when MOF is specifically targeted to a reporter in the absence of the full MSL complex, it conditions a strong increase in expression [Sun et al., 2013a] , the redistribution of MOF in the mle mutant males to cover the whole genome would be consistent with the retention of X chromosome compensation and any autosomal increases that are observed because more MOF is now associated with the autosomes than in normal males.
Dosage Compensation Does Not Involve the MSL Complex in Sciara
The Diptera are divided into 2 suborders. The Brachycera suborder includes Drosophila and the Nematocera includes Sciara ocellaris , which has also been studied with regard to dosage compensation. In Sciara , females are XX and males are XO, i.e. a single X and no Y chromosome. Studies of tritiated uridine incorporation into RNA from larval salivary gland chromosomes suggested similar rates for the single X in males compared to the 2 X chromosomes in females [da Cunha et al., 1994] . However, when the Drosophila antibodies to the MSL components, MLE, MSL3, MOF, and MSL1, were examined, they were found equally distributed across all chromosomes [Ruiz et al., 2000] . However, the MSL2 protein was not detected nor was it possible to detect it in Sciara DNA via Southern blot analysis. The data suggest that dosage compensation in Sciara occurs by upregulation of the single X chromosome, similarly to Drosophila , based on the density of tritiated uridine incorporation. However, the uniform distribution of most of the MSL components across the genome would suggest that it does not mediate dosage compensation in this species. A concentration on the X would not necessarily indicate that the MSL complex mediates compensation, in the absence of functional tests, but the failure to be associated specifically with the X would indicate a lack of involvement. The sex chromosomes in Diptera have shifted in numerous ways over evolutionary time [Vicoso and Bachtrog, 2015] and so the relationship of these 2 cases should be interpreted with caution at present. However, these studies indicate that in a sister group to Drosophila , X chromosome dosage compensation can clearly occur without the MSL complex and secondly that the MSL complex minus MSL2 likely has an independent function.
Gene Expression in msl Mutants
The question then arises as to whether there is a discrepancy between the sampling of X and autosomal genes in the mle mutations [Hiebert and Birchler, 1994 Bhadra et al., 2005] , noted above, compared to the original autoradiographic analysis [Belote and Lucchesi, 1980] . The autoradiographic data used a normalization in which the X values were divided by the autosomal values. In the context of the time, this type of analysis seemed reasonable for an internal control. However, when a re-examination of the autoradiographic data is performed, one can recognize that the absolute levels of grain counts on the X chromosome are not reduced in mutant males, and the absolute levels of the autosomal grain counts are increased. In the experiments in question, DNA replication values were also determined. If one normalizes the X and autosomal expression values to the DNA grain counts rather than the X to autosomal RNA synthesis values, as was performed in the study, then there is no loss of compensation of the X, and there is an increase in expression of the autosomes. Similar absolute results but with the same type of normalization were published for msl3 [Okuno et al., 1984] . Further, phenotypically the runt embryo developmental gene does not lose compensation in mle mutants [Gergen, 1987] . When viewed in this manner, there is no conflict between the original autoradiographic study and the sampling of X and autosomal gene expression studies. This interpretation of the autoradiographic data, however, is not consistent with the hypothesis that the MSL complex conditions X chromosome dosage compensation in males. Unfortunately, this type of normalization was adopted by other authors [Hamada et al., 2005; Deng and Meller, 2006, among others] reporting studies of gene expression in msl mutants or knockdowns with the recurring assumption that the autosomes do not change in expression. However, absolute measures indicate that this does not appear to be the case. Studies of RNA polymerase II occupancy on X-linked genes under different circumstances used the same type of autosomal normalization or reported global modulations of all chromosomes [Larschan et al., 2011; Conrad et al., 2012] , and thus the interpretation for these studies is also ambiguous. A recent re-analysis of global studies of dosage compensation when the MSL complex is dissociated concluded that compensation is often independent of the complex [Philip and Stenberg, 2013] . There is a growing realization in other systems of dosage compensation that global effects across the genome occur when the process is disrupted [de Clare et al., 2011; Kruesi et al., 2013] albeit distinctly from those in Drosophila . The redistribution of MOF in mle mutants and the finding of genome-wide effects of aneuploidy suggest that a global impact of MSL complex disruption is not unreasonable.
Many experiments to examine gene expression with MSL dissociation were performed using S2 tissue culture cells that are tetraploid and have 43 Mb of aneuploidy in an otherwise 120-Mb euchromatic genome [Zhang et al., 2010] . This aneuploid state will no doubt have an impact on global gene expression, and so it is not clear how well this experimental system can be related to what occurs in an organism. Indeed, in the heatmaps of MSL2 knockdown in S2 cells [Hamada et al., 2005] , there does appear to be some autosomal increase. However, there is also another consideration: if the amount of MOF is low in S2 cells, then there might in fact be a loss of compensation similar to that found in a mof ; mle genotype in embryos [Pal Bhadra et al., 2005] . This genotype is the only one examined in which the assayed genes show ∼ 50% expression in mutant males compared to normal males and females. These considerations illustrate the importance of conducting RNA-Seq experiments on the msl mutants in the organism itself in the context of interacting regulatory machineries.
Another question that arises is whether there is a unifying principle from the gene expression experiments. If one considers the data from the mle mutant males and from the metafemales together, it can be realized that there is an inverse relationship between a generalized pattern of gene expression and the dosage of the X chromosome [Birchler et al., 1989; Birchler, 1992 Birchler, , 1996 Sun et al., 2013b] . When coupled with a corresponding change in target gene expression on the X chromosome, then dosage compensation would result. In other words, in males there is a widespread approximately 2-fold increase in expression and in metafemales a two-thirds reduction. For the autosomes that do not change in dosage, this effect is directly manifested but is muted in normal males (see below). But for the X chromosome in which the assayed genes are also changed in dosage, the magnitude of the global effects will cancel the change in dosage of the assayed genes. This principle will also explain the inverse relationship of the change in expression of each X chromosome copy in triploid intersexes and triploid meta males. Such a response is reminiscent of the expression of genes in a dosage series of chromosome arms in maize [Birchler, 1979 [Birchler, , 1981 Birchler and Newton, 1981; Guo and Birchler, 1994] . Similar cases of 'autosomal dosage compensation' occur in flies in experimentally generated aneuploids and have a similar basis [Devlin et al., 1982 [Devlin et al., , 1988 Birchler et al., 1990; Sun et al., 2013c] . In a recent RNA-Seq study of trisomy 2L in flies compared to diploids [Sun et al., 2013c] , the inverse effect is also present similar to the trisomic X meta-females [Sun et al., 2013b] , illustrating that this effect is the prevalent response to changes in chromosomal dosage in Drosophila .
Ectopic Expression and Targeting of the MSL Complex
Returning to the MSL hypothesis, a straightforward prediction would be that ectopic targeting of the MSL complex to the X chromosome or a transgene would produce a 2-fold increase in expression given that this would mimic the situation in normal males, which this hypothesis suggests causes the 2-fold increase in expression. Indeed, in experiments conducted in yeast, appending the GAL4 DNA-binding domain to the MOF protein targeted the fusion protein to a reporter that was preceded by the upstream activating sequence recognized by the GAL4 DNA-binding domain [Akhtar and Becker, 2000] . When this targeting was conducted, the expression of the reporter was in fact increased about 10-fold. This yeast experiment was widely taken as evidence that targeting of MOF by the MSL complex to the X chromosome in flies was the basis of dosage compensation, but it assays MOF in isolation of other Drosophila cellular components.
By removing the binding sites for SXL from the MSL2 message, the protein can be expressed in females [Kelley et al., 1995] and the MSL complex is organized and localized to the X chromosomes. MOF is brought to the 2 X chromosomes and there is indeed an increase in H4K16Ac that can be readily visualized. However, when genes on the X are assayed for expression in these females, there are none that show any increase in expression [Bhadra et al., , 2000 Sun et al., 2013a] . Many autosomal genes in contrast are reduced in their expression Sun and Birchler, 2009] . As would be expected from the action of Sxl , mutations for this gene will allow the expression of MSL2 in females and localization to the X chromosomes. When endogenous genes were assayed for expression in an Sxl -genotype, again there was no evidence for an increase in expression of any gene studied [Bhadra et al., 2000] . Thus, a key prediction of the MSL hypothesis fails.
When MOF targeting to reporters was conducted in flies, there was a large increase in expression when females were examined but not in males where the MSL complex can be organized [Prestel et al., 2010; Sun et al., 2013a] . In both males and females, there was an increase of acetylation at the reporter, so an absence of histone modification cannot be attributed to the difference in gene expression. Thus, there appears to be a constraining activity in the MSL complex, or associated with the complex, that counteracts the effect of histone acetylation on gene expression. Further, when GAL4-MSL2 was targeted to the same reporters in males and females [Sun et al., 2013a] , there was no increase in expression as predicted by the MSL hypothesis but often a slight reduction in expression despite the fact that all assayed components of the MSL complex were associated with the reporter and histone acetylation was increased across the reporter. Ectopic expression of MSL2 in females with MOF targeting to reporters switched their response from upregulation to down, consistent with the idea of a constraining activity accompanying the MSL complex [Sun et al., 2013a] .
Indeed, when the MSL complex was dissociated from the X chromosome in roX mutants, the complex tended to become associated with heterochromatic regions of the chromosomes including the small 4th chromosome [Meller and Rattner, 2002; Figueiredo et al., 2014] . The new association of the MSL complex with 4th chromosome genes was documented by ChIP-Seq and found to be active in increasing the acetylation of H4K16. However, when the transcriptional output of these genes was compared to normal, there was no evidence for an increased expression. This result, in which there is no change in expression when genes transition from no association to being associated with the MSL complex, is similar to the deliberate targeting of reporters and ectopic expression in females [Sun et al., 2013a ].
An RNA-Seq experiment comparing females ectopically expressing MSL2 to normal females shows no evidence for increased expression of any X-linked endogenous genes despite an increased accumulation of the H4K16Ac on the X chromosomes [Sun et al., 2013a] . Thus, all of the multiple lines of evidence (in embryos, larvae and adults using transgene reporters and endogenous genes with assays on the RNA and phenotypic levels using GAL4-specific targeting or nonspecific MSL2 ectopic expression) suggest that the MSL complex does not confer an increased expression on genes when it becomes ectopically associated with them.
A question that arises is whether the lack of an effect of MSL targeting in females is due to a missing component present only in males. This possibility seems unlikely on multiple counts. Targeting of MSL2 to autosomal reporters in males fails to cause an increased expression [Sun et al., 2013a] . Further, the upregulation of reporters in females by targeting MOF alone can be reversed by the ectopic expression of MSL2 [Sun et al., 2013a] . Thus, all of the components to counteract the effect of histone acetylation on gene expression appear to be present in females.
As noted above, disruption of the MSL complex does not eliminate X chromosome dosage compensation. Together with the targeting results, the combined evidence suggests the need for a revised hypothesis for the role of the MSL complex.
Components of the Constraining Activity
An interesting phenotype of the male X chromosome occurs in mutations of various chromatin components. The male X chromosome is shorter and wider in mutants for the chromatin remodeling components ISWI [Brehm et al., 2000; Deuring et al., 2000] ( fig. 5 ) , nurf [Badenhorst et al., 2005] , JIL-1 kinase [Wang et al., 2001] , Topo2 [Hohl et al., 2012] , overexpression of DNA supercoiling factor [Furuhashi et al., 2006] and for the heterochromatin components, HP1 and Su(var)3-7 [Delattre et al., 2004; Spierer et al., 2005 Spierer et al., , 2008 among other conditions [Pal Bhadra et al., 2005] .
A role in gene repression was suggested for ISWI given that it localizes on polytene chromosomes independently of RNA polymerase II [Deuring et al., 2000] . In a subsequent study, the magnitude of the enlarged X phenotype was found to correlate with the amount of H4K16 acetylation [Corona et al., 2002] . The enlarged X phenotype is suppressed by the mof1 mutation, which strongly reduces the histone modification. It is potentially the case that ISWI and other genes with similar effects are involved in the override of histone acetylation or constraining activity by the MSL complex. One speculation is that these mutations release the MSL override, which would produce an extreme overexpression of the X as well as its bloated appearance. The results of Corona et al. [2002] with regards to the impact of levels of histone acetylation on the ISWI mutant phenotype are consistent with this idea. An examination of selected X and autosomal gene expression in the ISWI mutant embryos showed an overexpression of the X chromosome in males, which suggests that this protein is required for the process involved with overriding histone acetylation [Pal Bhadra et al., 2005] . Heterochromatin protein 1 (HP1) is enriched on the male X [de Wit et al., 2005 [de Wit et al., , 2008 and might play a role, but this possibility has not been explored.
A Model for the Function of the MSL Complex
The narrative above describes evidence that the MSL hypothesis for dosage compensation does not explain the various levels of gene expression that occur in compensating genotypes, as well as the results of ectopic expression and targeting. How then might one account for its presence on the X chromosome in males? Why is the MSL complex attracting an activator of gene expression to the X chromosome? A unifying explanation might be that the imbalance of the X chromosome relative to the remainder of the genome produces a widespread inverse effect on gene expression [Hiebert and Birchler, 1994; Birchler, 1996; Bhadra et al., 1999] . Such an effect can account for the different levels of compensation in both diploid and triploid flies including both reductions and increases in the dosage of the X chromosome that have been documented in Drosophila . The inverse dosage effect is likely a reflection of the stoichiometric interactions of multisubunit macromolecular complexes, and thus can be manifested in most aneuploids to some degree because any regulatory complex will exhibit the same kinetic properties [Veitia et al., 2008 [Veitia et al., , 2013 Birchler, 2010; Birchler and Veitia, 2012] . The MSL complex might have evolved to localize to the X chromosome so as to sequester the histone modifiers MOF and JIL1 kinase away from the autosomes to mute the inverse dosage effect that would otherwise occur there Pal Bhadra et al., 2005; Sun et al., 2013a, b] . With the increase in histone modifiers on the X, a constraining activity evolved to prevent overexpression. In essence, the sequestration process would be a reaction to genomic imbalance that occurs in normal males, and it would assure that the X is compensated but that the autosomes are not overexpressed.
With the degeneration of the Y chromosome to produce the heteromorphic sex chromosome situation, hemizygous regions of the X might be selected to acquire MOF for increased expression to survive. As the hemizygous region expands, further X-accumulated MOF would be coincident with autosomally depleted MOF, which would mute autosomal upregulation from an expanding inverse effect of the enlarging size of the hemizygous X region in males. As this process accelerates, an activity of the MSL complex might be selected to prevent overexpression due to the higher levels of acetylation now accumulating on the X but still allow dosage compensation to occur. The consequence of this scenario would be that the X chromosome in males is expressed near the level as the 2 X chromosomes in females, and the autosomes in the 2 sexes would be expressed at similar levels. However, when the MSL complex is dissociated in mutants, there is no constraining activity present and MOF becomes distributed uniformly across the genome . The autosomes would be expected to be increased in expression to some degree, for which experimental evidence exists. This evolutionary hypothesis is consistent with the normal and mutant results of MSL targeting and gene expression.
Resolution
The model that the MSL complex causes a 2-fold increase in the expression of the male X chromosome as the basis of dosage compensation is a simple concept. However, there are many aspects of the biology of dosage compensation that it does not explain. Dosage compensation in triple X metafemales [Stern, 1960] and the concomitant autosomal reductions in expression cannot be accounted for. Likewise, the tendency for male autosomal expression dimorphism is not explained. Other genotypes such as triploid intersexes and metamales have different levels of 'per gene' expression that association with the MSL complex does not readily accommodate. As noted above, triploid intersexes are mosaic for male and female tissues. It might be argued therefore that the intermediate expression results from an average expression from male and female cells. However, the phenotype of white-apricot in triploid intersexes (observed in the work of Rabinow et al. [1991] ) is not mosaic but uniformly similar to that of triploid females illustrating the true intermediate level of expression per gene. Furthermore, the targeting of the MSL complex to reporter transgenes or to the whole X chromosomes in females shows no evidence for an upregulation of the genes newly associated with the complex. Autosomal dosage compensation has been reported for several different aneuploids by multiple laboratories suggesting that compensation will inherently occur with a change of chromosomal dosage to some degree, and the MSL concept does not fit into this framework. In this vein, it lies outside the eukaryote-wide phenomenon of genomic balance effects on gene expression. The inverse effect model, however, is consistent with these findings in a general sense.
The unresolved issue seems to be whether there is a loss of dosage compensation of the X chromosome when the MSL complex is dissociated. As noted above, studies conducted in fly tissues suggest that a generalized loss of compensation does not occur and many increases in expression operate for the autosomes. If this is in fact the reality, then the method of normalization becomes an issue of whether it obscures the results. If the autosomes are inversely affected and they are used as the normalization standard, as is often the case, then the X chromosome values would be artificially reduced and would suggest a loss of compensation. In concert, the change in autosomal expression would be confounded by normalization to the same. Transcriptome size changes have been shown to be very difficult to decipher in microarray and RNA-Seq studies Doyle, 2010, 2015; Lovén et al., 2012; Birchler, 2014] . The situation is further complicated by the possibility that autosomal changes might alter the stoichiometry of regulatory machineries and indeed produce a spectrum of increases and decreases on all chromosomes under different circumstances as occurs in global studies of aneuploidy [Sun et al., 2013c] . If part of this spectrum included reductions of some X-linked genes, a focus on them might lead to the conclusion that there is loss of compensation when a more global change is indeed occurring. One study purports to have documented a loss of compensation when correcting for 'per cell' expression [Straub et al., 2005] . This study, however, was conducted in S2 tissue culture cells in which MSL2 had been knocked down by RNA interference. S2 cells are highly aneuploid, and there is evidence that there are other global changes in gene expression occurring in these cells [Zhang et al., 2010] . Another consideration is that the level of MOF might be low in S2 cells and consequently, when the MSL complex is disrupted, there may in fact be a generalized loss of compensation as occurs in the mof [1] ; mle double mutant genotype in embryos [Pal Bhadra et al., 2005] . Similar to the fact that targeting of MOF to a reporter in yeast [Akhtar and Becker, 2000] does not give the same result as targeting the MSL complex in flies [Bhadra et al., , 2000 Sun and Birchler, 2009; Sun et al., 2013a] , because it is out of the context of the fly cell, testing for loss of dosage compensation in S2 cells might not reflect the situation within the organism.
Indeed, there are distinctions between how autosomal monosomics comparable in genetic content to the X chromosome ( ∼ 20% of the genome) behave compared to the msl mutant males. The former are lethal at embryonic stages [Devlin et al., 1982] , but the msl -mutant males survive to the late larval stages and into the pupal stage. If there were in fact a loss of compensation in the msl -mutant males, the biology is different than an autosomal monosomic of the same size. Indeed, the mof[1];mle mutants are lethal in the embryonic stage. In this case, the loss of compensation is visually apparent in RNA-FISH experiments that do not make intragenomic normalizations but rather provide an absolute measurement of gene expression 'per cell'.
A resolution would come from conducting gene expression studies in fly tissues to insure that the cellular context is maintained. Normalization of global expression patterns should not correct to autosomal levels, given that one model to be distinguished suggests they are modulated, but rather to the DNA or via per cell methods. Procedures to estimate the transcriptome size are available Doyle, 2010, 2015] , but visualization methods per cell could also be used [Lovén et al., 2012; Birchler, 2014] . However, most RNA-Seq studies have an unwitting normalization built into them that obscures the transcriptome size [Lovén et al., 2012; Birchler, 2014; Coate and Doyle, 2015] . Thus, careful reflection on this matter is needed to move the field forward.
